BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 12447105)

  • 21. Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms.
    Longo JF; Weber SM; Turner-Ivey BP; Carroll SL
    Adv Anat Pathol; 2018 Sep; 25(5):353-368. PubMed ID: 29762158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathoracic peripheral nerve sheath tumors-a clinicopathological study of 75 cases.
    Boland JM; Colby TV; Folpe AL
    Hum Pathol; 2015 Mar; 46(3):419-25. PubMed ID: 25595633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologic classification of peripheral nerve tumors.
    Skovronsky DM; Oberholtzer JC
    Neurosurg Clin N Am; 2004 Apr; 15(2):157-66. PubMed ID: 15177315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microscopic intraneural perineurial cell proliferations in patients with neurofibromatosis type 1.
    Agaimy A
    Ann Diagn Pathol; 2014 Apr; 18(2):95-8. PubMed ID: 24461704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI features of benign peripheral nerve sheath tumors: how do sporadic and syndromic tumors differ?
    Debs P; Luna R; Fayad LM; Ahlawat S
    Skeletal Radiol; 2024 Apr; 53(4):709-723. PubMed ID: 37845504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.
    Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P
    Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurinomas-neurofibromas].
    Goujon JM; Bataille B; Menet E; Lapierre F
    Neurochirurgie; 1997; 43(1):35-8. PubMed ID: 9205625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
    Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraparotid facial nerve neurofibroma in neurofibromatosis type 1.
    Edizer DT; Hajizade Y; Karaman E; Cansiz H
    J Craniofac Surg; 2011 May; 22(3):1118-9. PubMed ID: 21586962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas.
    Wasa J; Nishida Y; Tsukushi S; Shido Y; Sugiura H; Nakashima H; Ishiguro N
    AJR Am J Roentgenol; 2010 Jun; 194(6):1568-74. PubMed ID: 20489098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse models of neurofibromatosis 1 and 2.
    Gutmann DH; Giovannini M
    Neoplasia; 2002; 4(4):279-90. PubMed ID: 12082543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant Peripheral Nerve Sheath Tumor.
    James AW; Shurell E; Singh A; Dry SM; Eilber FC
    Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology of the major peripheral nerve sheath neoplasms.
    Woodruff JM
    Monogr Pathol; 1996; 38():129-61. PubMed ID: 8744276
    [No Abstract]   [Full Text] [Related]  

  • 34. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
    Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
    Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.
    Brossier NM; Carroll SL
    Brain Res Bull; 2012 May; 88(1):58-71. PubMed ID: 21855613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant Peripheral Nerve Sheath Tumor Arising Within Lumbar Spinal Plexiform Neurofibroma.
    Alves Júnior SF; Pessoa Corrêa JA; Marchiori E
    World Neurosurg; 2019 Oct; 130():264-266. PubMed ID: 31323411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical study of GLUT-1 in oral peripheral nerve sheath tumors.
    Salla JT; Johann AC; Lana AM; do Carmo MA; Nunes FD; Mesquita RA
    Oral Dis; 2008 Sep; 14(6):510-3. PubMed ID: 18826382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis.
    Lévy P; Bièche I; Leroy K; Parfait B; Wechsler J; Laurendeau I; Wolkenstein P; Vidaud M; Vidaud D
    Clin Cancer Res; 2004 Jun; 10(11):3763-71. PubMed ID: 15173083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
    Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
    Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid perineurioma-neurofibroma in a patient with neurofibromatosis type 1, clinically mimicking malignant peripheral nerve sheath tumor.
    Inatomi Y; Ito T; Nagae K; Yamada Y; Kiyomatsu M; Nakano-Nakamura M; Uchi H; Oda Y; Furue M
    Eur J Dermatol; 2014; 24(3):412-3. PubMed ID: 24751814
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.